The FLUNITY-HD study, pooled analysis including 466,320 randomized older adults, demonstrated that high-dose inactivated influenza vaccine (HD-IIV) provided proven superior protection against hospitalization outcomes than standard-dose inactivated influenza vaccine (SD-IIV) among adults aged ≥65 years. Whether th...
K. Hosseini, N. Johansen, D. Modin et al.· European Heart Journal· 0 citations
BACKGROUND AND AIMS
Up to 30% of patients fail to respond after cardiac resynchronization therapy (CRT). While echocardiographic predictors of response are well described in de novo CRT, evidence in CRT upgrade populations remains limited. We investigated predictors of echocardiographic response in the BUDAPEST-CRT Upg...
E. Merkel, R. Masszi, B. Lakatos et al.· Clinical Research in Cardiol...· 0 citations
BACKGROUND
Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.· NEJM Evidence· 1 citation
BACKGROUND
Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...
C. Espersen, N. Johansen, D. Modin et al.· The Lancet Healthy Longevity· 0 citations
In adults aged 60 years or older, RSVpreF vaccination reduced hospitalisations for RSV-related respiratory tract disease with no statistical evidence of effect modification by immunosuppression status; however, the study was not powered to exclude subgroup differences.
A. Reimer Jensen, M. H. Højbjerg Lassen, N. Johansen et al.· The Lancet Healthy Longevity· 0 citations
BACKGROUND
Native T1 mapping is a contrast-free cardiac magnetic resonance (CMR) marker of myocardial amyloid infiltration, but center-specific diagnostic cutoffs and prognostic strata remain incompletely defined across transthyretin amyloidosis (ATTR).
OBJECTIVES
This study aims to define native T1 thresholds and ri...
Alberto Aimo, A. Sheikh, Sorayya Kakhi et al.· JACC Cardiovascular Imaging· 0 citations
Heart failure (HF) remains a major cause of morbidity, mortality, and increased healthcare costs worldwide, and is recognized as the result of progressive cardiovascular-kidney-metabolic (CKM) syndrome. Obesity, type 2 diabetes, chronic kidney disease, hypertension, and atherosclerotic cardiovascular disease frequently...
R. Inciardi, A. Abdin, M. Abdelhamid et al.· European Journal of Heart Fa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.